1. Cross-circulation: a milestone in cardiac surgery. JTCVS VOLUME 127, ISSUE 3, P617, MARCH 01, 2004
  2. 暫時停止心跳:開心英雄的故事/ King of hearts : the true story of the maverick who pioneered open heart surgery出版社:天下生活
  3. 心臟的故事 Heart: A History 出版社:究竟
  4. Piano MR. Alcohol's Effects on the Cardiovascular System. Alcohol Res. 2017;38(2):219-241. 2. 
  5. Zakhari, Samir. (2013). Alcohol Metabolism and Epigenetics Changes. Alcohol research : current reviews. 35. 6-16.
  6. Rizvi I, Zaman S, Zaidi N, et al. Superior vena cava syndrome caused by Hodgkin's lymphoma in an adolescent girl. BMJ Case Rep. 2012;2012:bcr0120125487. Published 2012 Feb 21. doi:10.1136/bcr.01.2012.5487
  7. Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Jr, Juliano, R. A., Jiao, L., Granowitz, C., Tardif, J. C., Ballantyne, C. M., & REDUCE-IT Investigators (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England journal of medicine, 380(1), 11–22.
  8. Hu Y, Hu FB, Manson JE. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants. J Am Heart Assoc. 2019;8(19)
  9. Matuz-Mares, D., Riveros-Rosas, H., Vilchis-Landeros, M. M., & Vázquez-Meza, H. (2021). Glutathione Participation in the Prevention of Cardiovascular Diseases. Antioxidants (Basel, Switzerland), 10 (8), 1220.
  10. Witkowski M, Weeks TL, Hazen SL. Gut Microbiota and Cardiovascular Disease. Circ Res. 2020;127(4):553-570. 
  11. O'Keefe JH, Torres-Acosta N, O'Keefe EL, et al. A Pesco-Mediterranean Diet With Intermittent Fasting: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(12):1484-1493. doi:10.1016/j.jacc.2020.07.049
  12. 心臟衰竭患者的生活改變指南 (美國心臟醫學會)
  13. The New Heart Failure Diet: Less Salt Restriction, More Micronutrients. J Gen Intern Med 25(10):1136–7
  14. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC Heart Fail. 2014 Jun;2(3):289-97
  15. Prevalence and mortality rate of congestive heart failure in the United States.J Am Coll Cardiol. 1992 Aug;20(2):301-6.
  16.  2017 ACC/AHA/HFSA 美國心臟衰竭治療指引
  17.  2016 ESC 歐洲心臟醫學會 急性與慢性心臟衰竭診斷與治療指引
  18. 美國心臟病醫學會(AHA) 
  19. 美國糖尿病醫學會(ADA) 
  20. 美國疾病管制局【抽菸與心血管疾病的關係】
  21. Cardiovascular Disease in Chronic Kidney Disease: March 16, 2021Vol 143, Issue 11 
  22. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;74:1823-1838.
  23. 2019 台灣腎臟病年報台灣腎臟醫學會
  24. 臨床評估腎臟功能方法之優缺點陳苓怡等內科學誌 2012:23:34-41
  25. 美國腎臟基金會網站
  26. 美國疾病管制局網站
  27. Restenosis of Drug-Eluting Stents.Circulation: Cardiovascular Interventions. Volume 12, Issue 8, August 2019
  28. Winslow, R.D., Sharma, S.K., & Kim, M.C. (2005). Restenosis and drug-eluting stents. The Mount Sinai journal of medicine, New York, 72 2, 81-9 .
  29. Thuijs, Daniel J F M et al. “Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.” Lancet (London, England) vol. 394,10206 (2019): 1325-1334. doi:10.1016/S0140-6736(19)31997-X
  30. Farkouh, Michael E et al. “Strategies for multivessel revascularization in patients with diabetes.” The New England journal of medicine vol. 367,25 (2012): 2375-84. doi:10.1056/NEJMoa1211585
  31. Bouabdallaoui, Nadia et al. “Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization.” Circulation. Heart failure vol. 11,11 (2018): e005531. doi:10.1161/CIRCHEARTFAILURE.118.005531
  32. 台灣醫學會
  33. 章魚壺心肌症 (Takotsubo Cardiomyopathy) 內科學誌 2019 陳郁安等
  34. BBC Future 新聞網
  35. 心臟病風險計算器
  36. 關於心臟不停跳手術 vs 心臟停跳手術的代表性研究:
  37. On-Pump versus Off-Pump Coronary-Artery Bypass Surgery(N Engl J Med 2013; 368:1189-1198)(RCT study, ROOBY Trial)文章結論:與傳統停跳手術比較,不停跳手術有顯著較高的 30 天死亡率、一年死亡率、併發症比例。
  38. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass (N Engl J Med 2017;377:623-32.)(RCT study: ROOBY-FS number, NCT01924442)文章結論:與傳統停跳手術比較,不停跳手術有顯著較高的五年死亡率、再次心肌梗塞率、併發症比例、需要二次手術比例。
  39. Changing the Discussion about On-Pump versus Off-Pump CABG (N Engl J Med 2017; 377:692-693)文章結論:不停跳手術開始流行於 90 年代、在美國,2002 年達到頂峰,有接近 25% 的繞道手術都使用不停跳手術。但之後由於陸續證實沒有好處、反而有害,比例開始逐年下降。
  40. Off-Pump versus On-Pump Coronary-Artery Bypass Grafting in Elderly Patients(N Engl J Med 2013; 368:1189-1198)文章結論:與傳統停跳手術比較,不停跳手術在 75 歲以上高齡病患族群,無法降低死亡率與病發症風險。
  41. 美國血管外科學會網站: S0003-4975(19)31687-X/fulltext
  42. Tang YS, Tsai YC, Chen TW, Li SY. Artificial Kidney Engineering: The Development of Dialysis Membranes for Blood Purification. Membranes (Basel). 2022;12(2):177. Published 2022 Feb 2. doi:10.3390/ membranes12020177